60 Degrees Pharmaceuticals, Inc. (SXTP) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.9
Day's range
$2.01

60 Degrees Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
KATHMERE CAPITAL MANAGEMENT, LLC 07/29/2026 265.10 K $466.58 K   83.23% 9.99%
CITADEL ADVISORS LLC 09/02/2026 22.36 K $39.36 K   100.00% 0.84%
XTX TOPCO LTD 08/14/2026 17.64 K $31.05 K   100.00% 0.66%
KOVACK ADVISORS, INC. 07/29/2026 15.00 K $26.40 K   100.00% 0.57%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 14.55 K $25.61 K   -10.70% 0.55%
UBS GROUP AG 08/13/2026 13.59 K $23.92 K   -56.73% 0.51%
BARCLAYS PLC 08/14/2026 1.05 K $1.85 K   -43.32% 0.04%
OSAIC HOLDINGS, INC. 08/14/2026 25 $44   0.00% 0.00%
CITIGROUP INC 08/03/2026 0 $0   -100.00% 0.00%
NEWEDGE ADVISORS, LLC 08/12/2026 0 $0   -100.00% 0.00%
TWIN PEAKS WEALTH ADVISORS, LLC 08/13/2026 0 $0   -100.00% 0.00%

60 Degrees Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 9 institutional investors and hedge funds held shares of 60 Degrees Pharmaceuticals Inc. The most heavily invested institutionals were:

CITADEL ADVISORS LLC: 22,362

XTX Topco Ltd: 17,639

Kovack Advisors, Inc.: 15,000

GEODE CAPITAL MANAGEMENT, LLC: 14,551

UBS Group AG: 13,592

BARCLAYS PLC: 1,052

13.16% of 60 Degrees Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 84.22 K shares in the last 24 months. This purchase volume represents approximately $162.55 K in transactions.